MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
AHR SELL REF $57.60 PW TARGET $47.04 (-18% vs spot · 12m PWEV) -18% Single-name research · 22 July 2026
Equity ResearchReal Estate · Health Care REITs
AHR

American Healthcare REIT, Inc. (AHR)

SELL. 12-month probability-weighted target $47 (-18% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

Verdict
SELL
Triangulated fair value $45.13 (-22% vs spot · triangulated FV)
Reference
$57.60
Close · 22 July 2026
PW Target
$47.04 (-18% vs spot · 12m PWEV) -18%
Probability-weighted
Horizon
12 mo
MCH Advisory
$45.13 (-22% vs spot · triangulated FV)
Fair value
$47.04 (-18% vs spot · 12m PWEV)
Scenario PWEV
34.3x
Forward P/E
$12B
Market cap
$35.95–$57.73
52-week range
Contents

Rating: SELL

SELL (5-tier) · cyclical compounder · conviction: medium

Metric Value
Current Price $57.60
Triangulated Fair Value $45.13 (-22% vs spot · triangulated FV)
12-mo Scenario PWEV $47.04 (-18% vs spot · 12m PWEV)
Forward P/E 34.3x
Market Cap $12B
52-Week Range $35.95–$57.73

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-07-21. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

Rating SELL · SELL (5-tier)
Classification · conviction cyclical compounder · medium
Triangulated fair value $45.13 (-22% vs spot · triangulated FV)
12-mo scenario PWEV $47.04 (-18% vs spot · 12m PWEV)
Next catalyst 2026-08-06 — Quarterly earnings
Primary thesis-break Organic revenue growth / order backlog < flat-to-negative for two consecutive quarters (2 consecutive prints)

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = SELL because:

  • Probability-weighted scenario value implies -18% vs spot
  • Monte Carlo median implies -27% vs spot
  • Bear case (Structural — Rate Shock / Oversupply / Secular Decline) downside is -58% vs spot
  • Net: reward/risk of 0.4× warrants a Sell.

Company Overview & Business Model

American Healthcare REIT, Inc. — REAL ESTATE · REIT - HEALTHCARE FACILITIES. American Healthcare REIT, Inc. is a prominent real estate investment trust focused on a diversified portfolio of high-quality healthcare assets across the United States, including senior housing, skilled nursing facilities, and medical office properties.

How it makes money.

Segment Rev mix Growth Op margin Key driver
Real Estate (FFO) 100% +5% 15% same-store NOI + occupancy + FFO growth + cap rates / interest rates +

Edge. None moat — Limited competitive moat (inferred from a 6% operating margin and 3% ROE and the 'reit_core' business model). Commodity / cyclical economics; terminal multiple should sit at or below the market.

Investment Thesis

[DRAFT — analyst to replace with a first-person thesis] At the current quote American Healthcare REIT, Inc. is trading rich to the engine's triangulated fair value (-17%). The business — American Healthcare REIT, Inc. — runs an operating margin near 6% on ~3% ROE. The engine's SELL rests on the 'reit_core' driver set and the cluster's house view; the bull case is upside re-rating if the demand cycle inflects.

The dashboard below is the whole argument on one page: spot ($57.60) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the $57.60 spot from $41.95 to $47.04 — stretched — spot sits above the skeptical blend.
Integrated dashboard. The five valuation anchors bracket the $57.60 spot from $41.95 to $47.04 — stretched — spot sits above the skeptical blend.

Anti-Thesis (The Real Bear Case)

[DRAFT — steelman for review] The bear case is a demand downcycle that compresses volumes and the 6% margin simultaneously, with the multiple de-rating as cyclical earnings roll over — the structural scenario in the model. For a mid-cap with thinner coverage, a single guidance cut can re-rate the stock faster than a large-cap peer.

Key Debate

Gross Margin explains 56% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.55 vs analyst floor +0.00delta +0.55 (n=28 mgmt / 25 Q&A; 83th pctile across the S&P book, z +1.0).

Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).

Quarter Mgmt Analyst Delta
2026Q1 +0.55 +0.00 +0.55
2025Q4 +0.58 +0.05 +0.52
2025Q3 +0.54 +0.47 +0.07
2025Q2 +0.62 +0.00 +0.62

News (last 365d, 350 articles): avg ticker sentiment +0.20 (bullish 27% / bearish 1%)

Scenario Analysis

The tree runs from a structural 'Structural — Rate Shock / Oversupply / Secular Decline' downside ($23.92) to a 'Bull — Cap-Rate Compression / Re-Rate' bull case ($73.46); the probability-weighted blend (PWEV $47.04) is -18% versus spot.

Scenario Probability Target Return vs spot
Structural — Rate Shock / Oversupply / Secular Decline 20% $23.92 -58%
Recession / Occupancy & SS-NOI Decline 17% $38.68 -33%
Base — FFO Growth + Stable Cap Rates 35% $49.47 -14%
Growth — Same-Store NOI + External Growth 20% $62.46 +8%
Bull — Cap-Rate Compression / Re-Rate 8% $73.46 +28%
Probability-Weighted (PWEV) $47.04 -18%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — Rate Shock / Oversupply / Secular Decline (20%, $23.92). Structural impairment — rate shock / oversupply / secular decline: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 23.92; probability: 0.2.
  • Recession / Occupancy & SS-NOI Decline (17%, $38.68). Cyclical downturn — same-store NOI + occupancy + FFO growth + cap rates / interest rates + dividend weakens for 1–2 years before normalising. Drivers — implied_target: 38.68; probability: 0.17.
  • Base — FFO Growth + Stable Cap Rates (35%, $49.47). Mid-cycle — normalised same-store NOI + occupancy + FFO growth + cap rates / interest rates + dividend; disciplined capital allocation; steady returns. Drivers — implied_target: 49.47; probability: 0.35.
  • Growth — Same-Store NOI + External Growth (20%, $62.46). Upside — NOI growth + cap-rate compression lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 62.46; probability: 0.2.
  • Bull — Cap-Rate Compression / Re-Rate (8%, $73.46). Upside tail — sustained tight conditions or a structural re-rate on NOI growth + cap-rate compression. Drivers — implied_target: 73.46; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the $57.60 spot; PWEV $47.04 (-18% vs spot · 12m). the payoff is skewed to the downside — upside to $73.46 against downside to $23.92
Five-scenario tree. Probability-weighted targets around the $57.60 spot; PWEV $47.04 (-18% vs spot · 12m). the payoff is skewed to the downside — upside to $73.46 against downside to $23.92

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $41.95 -27%
Peer EV/Revenue re-rate multiple $111 +93%
Scenario PWEV multiple $47.04 -18%
Triangulated (weighted) $45.13 -22%

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

FFO, P/FFO & Distributions

For a REIT, GAAP EPS is meaningless — depreciation is a massive non-cash charge, so REITs are valued on Funds From Operations (FFO ≈ net income + real-estate D&A) and P/FFO, not P/E. Every 'earnings' and 'multiple' figure in this report is therefore on an FFO basis.

Metric Value
FFO / share (trailing) $1.68
P/FFO (current) 33.7x
Dividend yield 1.8%

The valuation runs on FFO × P/FFO (the standard REIT frame); the cash-flow DCF is omitted (a REIT's development/maintenance capex is funded against the asset base, not free cash). The dividend yield (1.8%) is the income anchor; cap-rate / interest-rate moves and same-store NOI drive the scenarios.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $41.95 and 24% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (56% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

Monte Carlo distribution. Median $41.95; P(price > current) 24%. P10–P90: $21.11–$71.68.
Monte Carlo distribution. Median $41.95; P(price > current) 24%. P10–P90: $21.11–$71.68.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 10.83x) implies . A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 0% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 10.83x → —; EV/Rev re-rate → <img src=
Cross-sectional peer benchmarking. Peer-median fwd P/E 10.83x → —; EV/Rev re-rate → $111.

Across all anchors the spread is 147% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Real Estate (FFO) $2.4B 100% 5% 15% $0.4B 28x 15% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver same-store NOI + occupancy + FFO growth + cap rates / interest rates + dividend
net_debt_or_cash_b -1.43

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.15
div_yield 0.0177

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside rate shock / oversupply / secular decline
upside NOI growth + cap-rate compression

Industry Context — Real Estate

This name sits in the Real Estate as a reit_core. same-store NOI + occupancy + FFO growth + cap rates / interest rates + dividend Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: WPC (reit_core) · LAMR (reit_cyclical) · OHI (reit_core) · JLL (real_estate_services) · AMH (reit_core) · ELS (reit_core) · GLPI (reit_cyclical) · EGP (reit_growth) · AHR (reit_core) · CTRE (reit_core) · BRX (reit_core) · ADC (reit_core) · CUBE (reit_growth) · FR (reit_growth) · NNN (reit_core) · REXR (reit_growth) · VNO (reit_cyclical) · STAG (reit_growth) · HR (reit_core) · NSA (reit_core) · RYN (reit_cyclical) · KRG (reit_core) · CUZ (reit_cyclical) · SBRA (reit_core) · EPR (reit_cyclical) · KRC (reit_cyclical) · CDP (reit_cyclical) · IRT (reit_core) · PK (reit_cyclical)

Shared state Capex path House view This name implies
Rate Shock / Oversupply / Demand Loss 37% 37%
Mid-Cycle — FFO Growth + Stable Cap Rates 35% 35%
Upside — NOI Growth / Cap-Rate Compression 28% 28%

Mapping note: name-level 'Structural — Rate Shock / Oversupply / Secular Decline' (20%) + 'Recession / Occupancy & SS-NOI Decline' (17%) map to cluster Rate Shock / Oversupply / Demand Loss (37%); name-level 'Growth — Same-Store NOI + External Growth' (20%) + 'Bull — Cap-Rate Compression / Re-Rate' (8%) map to cluster Upside — NOI Growth / Cap-Rate Compression (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Rate Shock / Oversupply / Demand Loss () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The real_estate cycle is the shared macro driver. Driver — same-store NOI + occupancy + FFO growth + cap rates / interest rates + property demand Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Consensus & Market Expectations

Reference Value
Street target (mean) $59.36 (+3% vs spot · street)
House target $47.04 (-20.8% vs street)
Sell-side coverage 13 analysts (SB 5 / B 8 / H 0 / S 0 / SS 0; net score 0.69)
Consensus FY EPS $0.86; house above (+95.3%)
Consensus FY revenue $3.0B; house below (-18.1%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Metric Value
Net debt $1.6B — highly levered
Net debt / EBITDA 3.78x
Interest coverage (EBIT / interest) 1.6x
Current ratio 0.37x
Lease obligations $0.1B
Cash & ST investments $0.1B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $0.2B
Buybacks / dividends $0.0B / $0.2B
Total shareholder yield 1.4%
Payout as % of FCF 98.8%
Reinvestment (capex / OCF) 43.9%
SBC as % of FCF 9.0%
Allocation stance returns-heavy

Free-Cash-Flow Quality

Metric Value
FCF margin 6.9%
FCF conversion (FCF / net income) 233.8%
FCF yield 1.4%
Capex intensity (capex / revenue) 5.4%
FCF − SBC (diagnostic) $0.1B

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 414% — cash-backed.

Catalyst Calendar

  • 2026-08-06 (~16d) — Quarterly earnings — est. EPS $0.51 (AV EARNINGS_CALENDAR)
  • 2026-08-06 (~16d) — Quarterly earnings (AV EARNINGS_CALENDAR)

Forecast Track Record

  • EPS surprise: beat 37.5% of the last 8 quarters; average surprise -65.1%.

Competitive Moat

None moat. Limited competitive moat (inferred from a 6% operating margin and 3% ROE and the 'reit_core' business model). Commodity / cyclical economics; terminal multiple should sit at or below the market.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — Rate Shock / Oversupply / Secular Decline Cluster state 'Rate Shock / Oversupply / Demand Loss' (house prob ~37%) Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state.
Recession / Occupancy & SS-NOI Decline Cluster state 'Rate Shock / Oversupply / Demand Loss' (house prob ~37%) Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state.
Base — FFO Growth + Stable Cap Rates Cluster state 'Mid-Cycle — FFO Growth + Stable Cap Rates' (house prob ~35%) Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state.
Growth — Same-Store NOI + External Growth Cluster state 'Mid-Cycle — FFO Growth + Stable Cap Rates' (house prob ~35%) Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state.
Bull — Cap-Rate Compression / Re-Rate Cluster state 'Upside — NOI Growth / Cap-Rate Compression' (house prob ~28%) Path-dependency: a single disappointing print can shift the book toward the adjacent-bear state.

What the Market Is Pricing In

At the current price, the market pays 67.0× consensus forward EPS, and a peer median 10.83×.

Variant perception: the house view is below-consensus, and the thesis is primarily margin-driven.

Metric Consensus House Importance
Revenue 3.0 2.5 High
EPS 0.9 1.7 Medium
Target price 59.4 47.0 Medium

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
OHI 10.13× 5% 66% broad 25%
HR 10.83× 5% 12% broad 25%
SBRA 32.15× 5% 31% direct 100%

Quality-weighted forward P/E: 24.9× (simple median 10.83×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $35.95–$57.73, centre $45.60 (-21% vs spot); spot sits at the 99th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $45.13 (-22% vs spot · triangulated FV)
Downside to bear case (Structural — Rate Shock / Oversupply / Secular Decline) $23.92 (-58% vs spot · bear scenario)
Reward/risk ratio 0.4×
Margin of safety (FV vs spot) -28%
P(price > spot) — Monte Carlo 24%

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Cap-Rate Compression / Re-Rate): $73.46.

Assumption Register

Assumption Value Used in Source
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $2.4B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $2.5B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $0.86 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.21B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $1.571B reported fact Balance sheet via AV High EV, DCF equity bridge

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-07-21 Price, market cap, EV, 52-week range, forward P/E Alpha Vantage 2026-07-21
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-21 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-21 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-21 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-07-21 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-07-21 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-07-21 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-07-21 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-07-21 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-07-21 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-07-21 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 11/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

No DCF anchor is meaningful for this asset; the blend leans 62% on probability-weighted scenarios and 37% on the Monte Carlo median — the scenario probabilities are the load-bearing inputs.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Organic revenue growth / order backlog < flat-to-negative for two consecutive quarters (2 consecutive prints → real_estate). Sustained demand rollover breaks the base case toward the recession scenario.

Fact / Inference / Speculation

  • FACT: Spot $57.60; 52-week range $35.95–$57.73; engine rating SELL; house target $47.04 (-18%). (source: Alpha Vantage 2026-07-21, 22 July 2026)
  • INFERENCE: Triangulated FV $45.13 (-22% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core.
  • SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Recommendation: SELL

Defensive: rating SELL; triangulated fair value $45.13 (-22% vs spot) — the risk/reward is skewed to the downside on Gross Margin. The debate is Gross Margin — a fundamental call.

Options Overlay

A defined-risk way to express the SELL equity view. Chain as of 2026-07-21 (last close) — indicative, not executable quotes.

Market signalsATM IV 35.6% (moderate regime) · expected move ±9.8% (2026-08-21) · put/call OI 0.08 · ATM Δ 0.407 / Θ -0.048 / ν 0.065 · next earnings 2026-08-06. Direction: SHORT/HEDGE (implied return -21.6% to triangulated fair value $45.13).

Bear Put Spread (Bearish) — Long 60 P / Short 45 P · 2027-01-15 · net debit $4.33 · max profit $10.68 · breakeven $55.67 · RoR 247% · max loss $4.33 · live chain

Defined-risk downside expression: the debit caps the loss, with the position gaining as the stock falls toward the lower strike — a way to act on a bearish view without shorting stock. Illustrative — no outcome is implied or guaranteed.

Protective Put (if held) (Hedge) — Long 60 P · 2027-01-15 · premium $5.9 · floor 4% · max loss $5.9 · live chain

Insurance for an existing holding — a known premium buys a floor while leaving the upside intact. A way to hold through a binary event or volatility with defined downside. Illustrative — no outcome is implied or guaranteed.

Protective Collar (if held) (Hedge) — Long 50 P / Short 65 C · 2027-01-15 · net $0.4 · floor -13% · cap +13% · live chain

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling. Illustrative — no outcome is implied or guaranteed.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Data Sources

  • Prices, fundamentals, options chain, earnings — Alpha Vantage.
  • Company filings (10-K / 10-Q)SEC filings via EDGAR.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.
Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.